Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease

Alzheimer’s disease, a devastating neurodegenerative disorder, is characterized by progressive cognitive decline, primarily due to amyloid-beta protein deposition and tau protein phosphorylation. Effectively reducing the cytotoxicity of amyloid-beta42 aggregates and tau oligomers may help slow the p...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sha Sha, Lina Ren, Xiaona Xing, Wanshu Guo, Yan Wang, Ying Li, Yunpeng Cao, Le Qu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2026-02-01
Series:	Neural Regeneration Research
Assuntos:	alzheimer’s disease amyloid deposits amyloid-beta antibody cognitive dysfunction dementia immunotherapy oligomer preventive immunization tau hyperphosphorylation
Acceso en liña:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00846
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!